Mitsuo Shimada

A Risk Model for Esophagectomy Using Data of 5354 Patients Included in a Japanese Nationwide Web-Based Database

Hiroya Takeuchi, Hiroaki Miyata, Mitsukazu Gotoh et al. · Annals of Surgery · 2014 · 598 citations

Medicine, Perioperative Medicine, Surgery +17

Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update

Norihiro Kokudo, Nobuyuki Takemura, Kiyoshi Hasegawa et al. · Hepatology Research · 2019 · 533 citations

Medicine, Oncology, Cancer Control +16

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer

Hideki Ueno, T Kosuge, Y Matsuyama et al. · British Journal of Cancer · 2009 · 440 citations · Full text

Medicine, Oncology, Surgery +14

Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume

Ken Shirabe, Mitsuo Shimada, Tomonobu Gion et al. · Journal of the American College of Surgeons · 1999 · 433 citations · Full text

Medicine, Oncology, Surgery +14